These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2943688)

  • 1. Modulation of human T-cell suppressor activity by beta endorphin and glycyl-L-glutamine.
    McCain HW; Lamster IB; Bilotta J
    Int J Immunopharmacol; 1986; 8(4):443-6. PubMed ID: 2943688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endorphinergic modulation of immune function: potent action of the dipeptide glycyl-L-glutamine.
    McCain HW; Bilotta J; Lamster IB
    Life Sci; 1987 Jul; 41(2):169-76. PubMed ID: 2955182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
    Brown SL; Van Epps DE
    J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Endorphin enhances lymphocyte proliferative responses.
    Gilman SC; Schwartz JM; Milner RJ; Bloom FE; Feldman JD
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4226-30. PubMed ID: 6287475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms.
    McCain HW; Lamster IB; Bozzone JM; Grbic JT
    Life Sci; 1982 Oct; 31(15):1619-24. PubMed ID: 6292642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyl glutamine, an inhibitory neuropeptide derived from beta-endorphin.
    Parish DC; Smyth DG; Normanton JR; Wolstencroft JH
    Nature; 1983 Nov 17-23; 306(5940):267-70. PubMed ID: 6316148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal tetrapeptide of beta-endorphin (MPF) enhances lymphocyte proliferative responses.
    Owen DL; Morley JS; Ensor DM; Miles JB
    Neuropeptides; 1998 Apr; 32(2):131-9. PubMed ID: 9639251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal dipeptide of beta-endorphin: a neuropeptide with inhibitory activity.
    Smyth DG; Parish DC; Normanton JR; Wolstencroft JH
    Life Sci; 1983; 33 Suppl 1():575-8. PubMed ID: 6319912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of lymphocyte function by endorphins.
    Heijnen CJ; Croiset G; Zijlstra J; Ballieux RE
    Ann N Y Acad Sci; 1987; 496():161-5. PubMed ID: 2955727
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro effects of 4-hydroperoxycyclophosphamide on concanavalin A-induced human suppressor T cells.
    Klajman A; Drucker I; Manor Y; Ben-Efraim S
    Cancer Immunol Immunother; 1984; 18(2):113-7. PubMed ID: 6239682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human concanavalin A-induced lymphocyte proliferative response by physiological concentrations of beta-endorphin.
    Fontana L; Fattorossi A; D'Amelio R; Migliorati A; Perricone R
    Immunopharmacology; 1987 Apr; 13(2):111-5. PubMed ID: 2954928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-endorphin-induced cardiorespiratory depression is inhibited by glycyl-L-glutamine, a dipeptide derived from beta-endorphin processing.
    Unal CB; Owen MD; Millington WR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):952-8. PubMed ID: 7965817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte proliferation is possible with low concentrations of glycyl-glutamine.
    Köhler H; Hartig-Knecht H; Rüggeberg J; Adam R; Schroten H
    Eur J Nutr; 2000 Jun; 39(3):103-5. PubMed ID: 10918991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-endorphin inhibits interleukin-2 release and expression of interleukin-2 receptors in concanavalin A-stimulated splenic lymphocytes.
    Garcia I; Perez-Castillo A; Moreno J; Alemany S
    Lymphokine Cytokine Res; 1992 Dec; 11(6):339-45. PubMed ID: 1477186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of suppressor T cell activity by lymphocyte promoting factor of Bordetella pertussis.
    Huang SW
    Immunopharmacol Immunotoxicol; 1990; 12(1):61-76. PubMed ID: 2141034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal regulatory peptides modulate mouse lymphocyte functions under serum-free conditions in vitro.
    Krco CJ; Gores A; Go VL
    Immunol Invest; 1986 Apr; 15(2):103-11. PubMed ID: 2427444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of beta-endorphin fragments on human natural killing.
    Williamson SA; Knight RA; Lightman SL; Hobbs JR
    Brain Behav Immun; 1987 Dec; 1(4):329-35. PubMed ID: 2898956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte electrophoresis as an indicator of modulation of concanavalin A-induced suppressor T-cells in vivo by anti-cancer drugs.
    Shimizu M; Sekine K; Kataoka T; Iwaguchi T
    Int J Immunopharmacol; 1990; 12(5):545-51. PubMed ID: 2145240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating effect of beta-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate.
    Nordlind K; Mutt V
    Int Arch Allergy Appl Immunol; 1986; 81(4):368-70. PubMed ID: 2430896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.